Critical role of miR-10b in transforming growth factor-β1-induced epithelial-mesenchymal transition in breast cancer

Cancer Gene Therapy

Volumn 21, Issue 2, 2014, Pages 60-67

  Han, Xu ^a   Yan, Sun ^a   Weijie, Zhang ^a   Feng, Wang ^a   Liuxing, Wang ^a   Mengquan, Li ^a   Qingxia, Fan ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

E cadherin; EMT; invasion; miR 10b; TGF b1

Indexed keywords

ANALYSIS OF VARIANCE; BLOTTING, WESTERN; BREAST NEOPLASMS; CADHERINS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA, COMPLEMENTARY; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; REAL-TIME POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA1; VIMENTIN;

EID: 84894275355     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2013.82     Document Type: Article

References (37)

1. Wu Q. Risks for breast cancer in Chinese female: a systematic review. Mod Prevent Med 2011; 38: 61-72.
2. Deakin NO, Turner CE. Distinct roles for paxillin and Hic-5 in regulating breast cancer cell morphology, invasion, and metastasis. Mol Biol Cell 2011; 22: 327-341.
3. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial- mesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7: 131-142.
4. Yang J, Weinberg RA. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 2008; 14: 818-829.
5. Nieto MA. The ins and outs of the epithelial to mesenchymal transition in health and disease. Annu Rev Cell Dev Biol 2011; 27: 347-376.
6. Gunaratne A, Thai BL, Di Guglielmo GM. Atypical protein kinase C phosphorylates Par6 and facilitates transforming growth factor b-induced epithelialto-mesenchymal transition. Mol Cell Biol 2013; 33: 874-886.
7. Korc M, Friesel RE. The role of fibroblast growth factors in tumor growth. Curr Cancer Drug Targets 2009; 9: 639-651.
8. Schö nrath K, Klein-Szanto AJ, Braunewell KH. The putative tumor suppressor VILIP-1 counteracts epidermal growth factor-induced epidermal-mesenchymal transition in squamous carcinoma cells. PLoS ONE 2012; 7: e33116.
9. Ogunwobi OO, Liu C. Hepatocyte growth factor upregulation promotes carcinogenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathways. Clin Exp Metastasis 2011; 28: 721-731.
10. Witsch E, Sela M, Yarden Y. Roles for growth factors in cancer progression. Physiology (Bethesda) 2010; 25: 85-101.
11. Kim MK, Maeng YI, Sung WJ, Oh HK, Park JB, Yoon GS et al. The differential expression of TGF-b1, ILK and wnt signaling inducing epithelial to mesenchymal transition in human renal fibrogenesis: an immunohistochemical study. Int J Clin Exp Pathol 2013; 6: 1747-1758.
12. Radisky ES, Radisky DC. Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer. J Mammary Gland Biol Neoplasia 2010; 15: 201-212.
13. Yan C, GrimmWA, Garner WL, Qin L, Travis T, Tan N et al. Epithelial to mesenchymal transition in human skin wound healing is induced by tumor necrosis factor-a through bone morphogenic protein-2. Am J Pathol 2010; 176: 2247-2258.
14. Wendt MK, Tian M, Schiemann WP. Deconstructing the mechanisms and consequences of TGF-b-induced EMT during cancer progression. Cell Tissue Res 2012; 347: 85-101.
15. Connolly EC, Freimuth J, Akhurst RJ. Akhurst. complexities of TGF-b targeted cancer therapy. Int J Biol Sci 2012; 8: 964-978.
16. Schetter AJ, Okayama H, Harris CC. The role of microRNAs in colorectal cancer. Cancer J 2012; 18: 244-252.
17. Iorio MV, Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 2012; 4: 143-159.
18. Romero-Cordoba S, Rodriguez-Cuevas S, Rebollar-Vega R, Quintanar-Jurado V, Maffuz-Aziz A, Jimenez-Sanchez G et al. Identification and pathway analysis of microRNAs with no previous involvement in breast cancer. PLoS ONE 2012; 7: e31904.
19. Schetter AJ, Harris CC. Alterations of microRNAs contribute to colon carcinogenesis. Semin Oncol 2011; 38: 734-742.
20. Zhang ZJ, Ma SL. miRNAs in breast cancer tumorigenesis (Review). Oncol Rep 2012; 27: 903-910.
21. Ma L. Role of miR-10b in breast cancer metastasis. Breast Cancer Res 2010; 12: 210.
22. Ma L, Reinhardt F, Pan E, Soutschek J, Bhat B, Marcusson EG et al. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol 2010; 28: 341-347.
23. Li X, Xu F, Chang C, Byon J, Papayannopoulou T, Deeg HJ et al. Transcriptional regulation of miR-10a/b by TWIST-1 in myelodysplastic syndromes. Haematologica 2013; 98: 414-419.
24. Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, Weinberg RA.. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 2008; 68: 3645-3654.
25. Gupta M, Korol A, West-Mays JA. Nuclear translocation of myocardin-related transcription factor-A during transforming growth factor beta-induced epithelial to mesenchymal transition of lens epithelial cells. Mol Vis 2013; 19: 1017-1028.
26. Qian H, Yu J, Li Y et al. RNA interference of metastasis-associated gene 1 inhibits metastasis of B16F10 melanoma cells in a C57BL/6 mouse model. Biol Cell 2007; 99: 573-581.
27. Rao Y, Wang H, Fan L, Chen G.. Silencing MTA1 by RNAi reverses adhesion, migration and invasiveness of cervical cancer cells (SiHa) via altered expression of p53, and E-cadherin/b-catenin complex. J Huazhong Univ Sci Technolog Med Sci 2011; 31: 1-9.
28. Saito A, Suzuki HI, Horie M, Ohshima M, Morishita Y, Abiko Y et al. An integrated expression profiling reveals target genes of TGF-b and TNF-a possibly mediated by microRNAs in lung cancer cells. PLoS ONE 2013; 8: e56587.
29. Wendt MK, Allington TM, Schiemann WP.. Mechanisms of the epithelialmesenchymal transition by TGF-beta. Future Oncol 2009; 5: 1145-1168.
30. Baum B, Settleman J, Quinlan MP. Transitions between epithelial and mesenchymal states in development and disease. Semin Cell Dev Biol 2008; 19: 294-308.
31. Micalizzi DS, Farabaugh SM, Ford HL. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia 2010; 15: 117-134.
32. Taylor MA, Parvani JG, Schiemann WP. The pathophysiology of epithelialmesenchymal transition induced by transforming growth factor-b in normal and malignant mammary epithelial cells. J Mammary Gland Biol Neoplasia 2010; 15: 169-190.
33. Iorio MV, Croce CM. Causes and consequences of microRNA dysregulation. Cancer J 2012; 18: 215-222.
34. Liu Y, Zhao J, Zhang PY, Zhang Y, Sun SY, Yu SY et al. MicroRNA-10b targets E-cadherin and modulates breast cancer metastasis. Med Sci Monit 2012; 18: BR299-BR308.
35. Misra A, Pandey C, Sze SK, Thanabalu T. Hypoxia activated EGFR signaling induces epithelial to mesenchymal transition (EMT). PLoS ONE 2012; 7: e49766.
36. Miettinen PJ, Ebner R, Lopez AR, Derynck R.. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol 1994; 127(6 Pt 2): 2021-2036.
37. Taylor MD, Liu Y, Nagji AS, Theodosakis N, Jones DR.. Combined proteasome and histone deacetylase inhibition attenuates epithelial-mesenchymal transition through E-cadherin in esophageal cancer cells. J Thorac Cardiovasc Surg 2010; 139: 1224-1232.